When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objectives: It is unclear whether insulin-like growth factor (IGF) function is involved in the pathophysiology of chronic fatigue syndrome (CFS).Unpublished data and reports in patient organization newsletters suggest that Acclydine, a food supplement, could be effective in the treatment of CFS by increasing biologically active IGF1 levels.Here we aimed to measure the IGF1 and IGF binding protein (IGFBP) 3 status of CFS patients compared to age-and gendermatched neighborhood controls, and to assess the effect of Acclydine on fatigue severity, functional impairment, and biologically active IGF1 level (IGFBP3/IGF1 ratio).Design: A randomized, placebo-controlled, double-blind clinical trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845 · cited 1×
“[6] compared published articles with protocols for 102 randomized trials approved by the Scientific-Ethical Committees for Copenhagen and Frederiksberg, Denmark in 1994–1995,”
MethodOutcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
Chan, A.-W. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041086 · Cited by 444
Cited by
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
Vedula, S. S., Bero, L., Scherer, R. W., & Dickersin, K. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0906126 · Cited by 361
Dimairo, M., Pallmann, P., Wason, J., Todd, S., Jaki, T., Julious, S. A., Mander, A. P., Weir, C. J., Koenig, F., Walton, M. K., et al. (2020) · Trials · doi:10.1186/s13063-020-04334-x · Cited by 58
Brancati, F. L., Evans, M., Furberg, C. D., Geller, N., Haffner, S., Kahn, S. E., Kaufmann, P. G., Lewis, C. E., Nathan, D. M., Pitt, B., et al. (2012) · Clinical Trials · doi:10.1177/1740774511432726 · Cited by 34
“Evans [24] poses a series of questions to trialists who are considering a change: (1) What data triggered the review? (2) Have interim results been reviewed? (3) Who is making the decision? Ideally, endpoint reviews would be triggered by factors other than low event rates (e.”
BackgroundInfluentialExploring the role and function of trial steering committees: results of an expert panel meeting
Harman, N. L., Conroy, E. J., Lewis, S. C., Murray, G., Norrie, J., Sydes, M. R., Lane, J. A., Altman, D. G., Baigent, C., Bliss, J. M., et al. (2015) · Trials · doi:10.1186/s13063-015-1125-z · Cited by 33
“Examples of such matters include changes to primary outcome [12, 13], amendments to statistical analysis plans, and planned sample size.”
Self-citation
Metadata
- Authors
- Evans, S.
- Venue
- PLoS Clinical Trials
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-04-13
- Volume
- 2
- Issue
- 4
- Pages
- e18
- ISSN
- 1555-5887 (ISSN-L)
- OpenAlex
- W2033856221
- Cited by
- 88
- References
- 3
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial. https://app.cochat.ai/papers/10.1371/journal.pctr.0020018
- The paper
- Evans, S. (2007). When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial. PLoS Clinical Trials. https://doi.org/10.1371/journal.pctr.0020018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.